Barclays analyst Andrew Mok raised the price target on Molina Healthcare (NYSE: MOH) to $161.00 (from $133.00) while maintaining a Underweight rating.

The analyst commented, "Revising PT: We maintain our 2026 and 2027 EPS estimates and raise our PT from $133 to $161 on a higher 12x P/E (was 11x) on our 2027 EPS to reflect signs of stabilization in the Medicaid business and encouraging underlying cost trends."